Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06233799 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting Site details revised at 11 of 11 sitesv12 Show 1 more changeShow less
    • Site details revised at 11 of 11 sites
  2. Re-verified, no change to tracked fieldsv11
  3. Site details revised at 2 of 11 sitesv10
  4. Site contacts updated at 1 of 11 sitesv9
  5. Site details revised at 1 of 11 sitesv8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 10 to 11v7
  2. Re-verified, no change to tracked fieldsv6
  3. Site contacts updated at 1 of 10 sitesv5
  4. Site details revised at 4 of 10 sitesv4
  5. Study sites: 7 to 10v3
  6. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 7 · Start date changed from estimate of May 1, 2024 to Jul 1, 2024v2 Show 2 more changesShow less
    • Study sites: 0 to 7
    • Start date changed from estimate of May 1, 2024 to Jul 1, 2024
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing methamphetamine (MA) use in individuals with moderate or severe methamphetamine use disorder (MUD) seeking to stop or reduce MA use.
Trial Details
NCT Number NCT06233799
Lead Sponsor National Institute on Drug Abuse (NIDA)
Conditions Methamphetamine-dependence, Methamphetamine Abuse
Enrollment 360 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov